Richard Alan McIndoe
Associate Professor
Associate Director, Center for Biotechnology Phone: (706) 733-0188 x2392
and Genomic Medicine FAX: (706) 823-2269
Medical College of Georgia
rmcindoe@mail.mcg.edu
Augusta, GA 30912
Experience
7/02 – present Associate Professor
Associate Director, Center for Biotechnology and Genomic Medicine
Medical College of Georgia, Augusta, GA
11/99-6/02 Assistant Professor
Department of Pathology
University of Florida, Gainesville, FL
3/99-10/99 Group Leader
Full Length Cloning Facility
CuraGen Corporation, Alachua, FL
11/97-3/99 Senior Research Scientist
Full Length Cloning Facility
CuraGen Corporation, Alachua, FL
10/98-11/99 Courtesy Assistant Professor
Biotechnology Program
University of Florida, Gainesville, FL
1997-present Board of Directors
The Institute for Science Training and
Research, Inc.
Seattle, WA
1997 Research Associate
Department of Molecular Biotechnology
University of Washington, Seattle, WA
1996-1997 Vice President, Consulting Division
The Institute for Science Training and Research,
Inc.
Seattle, WA.
1992-1997 Postdoctoral Fellow, (Leroy Hood, M.D., Ph.D.-Advisor)
Department of Molecular Biotechnology,
University of Washington , Seattle, WA
1991-1992 Postdoctoral Assistant; (Edward K. Wakeland Ph.D.-Advisor)
Department of Pathology and Laboratory
Medicine,
University of Florida, Gainesville, FL
1984-1986 Laboratory Technician,
Department of Pathology and Laboratory Medicine,
University of Florida, Gainesville, FL
Education:
1984 B.S. in Microbiology and Cell Science;
University of Florida, Gainesville, FL
1991 Ph.D. in Immunology and Molecular Pathology;
Edward K. Wakeland, Ph.D. –Advisor,
Department of Pathology and Laboratory Medicine,
University of Florida, Gainesville, FL
Computer Experience:
Professional History
Medical College of Georgia
Augusta, GA
Associate Professor 2002 – present
Associate Director, Center for Biotechnology and Genomic Medicine
Research interests include bioinformatics, automation, autoimmunity, and diabetes. The research efforts focus on
building the computing infrastructure for management of microarray data and looking at the temporal gene expression changes during the etiology of diabetes in rodent and human
populations.
University of Florida
Gainesville, FL
Assistant Professor 1999 - 2002
Research interests include bioinformatics, automation, autoimmunity, and diabetes. The research efforts focus on
building the computing infrastructure for management of microarray data and looking at the temporal gene expression changes during the etiology of diabetes in rodent and human
populations.
Molecular Staging, Inc.
66 High Street
Guilford, CT
Consultant – Polymorphism Detection Group 1999
Principle responsibility was to design and implement the high throughput polymorphism detection facility of the
Positional Cloning group. Building the infrastructure for this process included hiring responsibilities, workflow design, automation design, SOP development, design of the database
schema, writing web based data management/workflow code and order the reagents and equipment.
CuraGen Corporation
12085 Research Drive
Alachua, FL 32615
Group Leader - Full Length Cloning Facility 1997-1999
Responsibilities and achievements include the design and implementation of a high throughput Full Length Cloning
facility. The development of the infrastructure for this process included software and hardware solutions as well as the ability to build a team of qualified individuals.
Highlights:
¨
Design and implementation of a high throughput Full Length Cloning facility
¨
Develop software solutions for the facility in conjunction with in-house bioinformatics team.
¨
Design and optimize process workflow to increase efficiency of full length cloning process.
¨
Build a team of scientists and technicians to produce weekly goals.
¨
Managed a team of five Ph.D. level scientists and 14 Research Associates
¨
Responsible for yearly operations plan, budgets, costing analysis and bi-weekly project allocations.
University of Washington
Leroy Hood, M.D. , Ph.D.
Seattle, WA
Postdoctoral fellow/Research Associate 1992-1997
Research efforts at the University of Washington had primarily focused on the development and implementation of a high
throughput genotyping facility as well as mapping susceptibility loci for complex common diseases. A critical evaluation of data flow for a genotyping facility lead to both hardware
and software solutions in the areas of sample cataloging and disbursement, gel documentation and archiving, and genotype data capture. The goal of this work was to develop seamless
integration between the sample cataloging, sample preparation, genotype data collection and genotype data capture. To this end, a number of databases with suitable front end forms
were written to track sample movement as well as genotyping software to fully automate the data capture. Currently, a number of laboratories in the US and Canada are using our
software and it is commercially available through an exclusive license to the LiCor Corporation. I also advised other laboratories/companies concerning the day to day operation of a
genotyping facility.
My laboratory had four genetic mapping projects under way. The first mapping project involved linkage analysis of
high risk families for prostate cancer. This project was part of the CapCURE prostate cancer consortium and was in collaboration with Elaine Ostrander at the Fred Hutchinson Cancer
Research Center. The second project involved linkage analysis of high risk families with Rheumatoid arthritis in a local Native American tribe (Yakima Indians). We were in the family
collection phase of this project when I left the University of Washington. The third project involved mapping susceptibility loci in a Rheumatoid arthritis-like mouse animal model
called Collagen Induced Arthritis. The final project was the same as the previous one with the exception of using a different strain of mouse, B10.RIII. We had reason to suspect this
strain will have unique loci involved in the disease and want to test for disease stratification.
University of Florida
Edward K. Wakeland, Ph.D.
Gainesville, FL
Ph.D. Candidate 1987-1991
Previous interests involved immunogenetics and the mouse major histocompatibility complex (Mhc). In
particular, I was interested in the origin of Mhc class II gene polymorphisms as well as the tissue specific regulation of these genes. We determined that most (> 90%) of the
polymorphisms found in the class II genes of the mouse Mhc had survived many speciation events and were most likely due to the steady accumulation of mutations over long
evolutionary periods. This was in stark contrast to pathogen driven hypermutation events proposed by others. In addition, I characterized the regulatory elements of one of these
class II genes, the Ab gene. An assessment of the chromatin structure revealed a potential enhancer in the second intron. This was later confirmed via transient transfection assays
into B cells.
Honors and Awards:
1993-1996 NRSA: "Mapping the Non-Mhc genes influencing collagen induced arthritis”Awarded by: National Institutes of Arthritis and Musculoskeletal
and Skin Diseases,
1994-1997 NSF: "Design of a Hands-on Biology course for Elementary Science
Teachers".
1996-1997 CapCURE: "Genetic mapping of prostate cancer loci in high risk families"
Renewed on a yearly basis.
1996-1997 Darwin Molecular:"Mapping Susceptibility Loci for Rheumatoid Arthritis in a
Native American Tribe" Renewed on a
yearly basis.
2000-2001
Howard Hughes Medical Institute Biomedical Research Support
Study Sections:
2001 ZNS1 SRB-W (01) NINDS/NIMH Microarray Center & Review Committee
2002 ZAI1-ALR-M-M1 NIAID Unsolicited Program Project Grant
2002 ZDK1-GRB-3 (01) NIDDK MTOPS Prostate Samples Analysis Consortium
2002 ZDK1-GRB-2 (C1) NIDDK BioSample and Genetics Repositories

Getting Started:
Visit our Site Map to see what is available or use the navigation menu to the left.